Search Within

Aaron David Viny

  1. "Computational Oncology Service"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Computational Oncology Service (7)
  4. Department of Medicine (7)
  5. Epidemiology and Biostatistics (7)
  6. Executive Committee, Center for Hematologic Malignancies (7)

More Groups

People
  1. Elli Papaemmanuil (7)
  2. Christopher Famulare (6)
  3. Ross Levine (6)
  4. Minal Patel (5)
  5. Kamal Menghrajani (4)
  6. Maria Arcila (4)

More People

Years
  1. 2023 (2)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (2)
  5. 2018 (1)
Publications
  1. Blood (4)
  2. American Journal of Hematology (2)
  3. Clinical Cancer Research (1)
Publishers
  1. American Society of Hematology (4)
  2. John Wiley & Sons, Inc. (2)
  3. American Association for Cancer Research (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Meeting Abstract

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; Nadorp, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Recurrent mutations in cyclin D3 confer clinical resistance to FLT3 inhibitors in acute myeloid leukemia
    Journal Article

    Smith, C. C.; Viny, A. D.; Massi, E.; Kandoth, C.; Socci, N. D.; Rapaport, F.; Najm, M.; Medina-Martinez, J. S.; Papaemmanuil, E.; Tarver, T. C.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Single cell DNA sequencing identifies combinatorial mutation patterns and clonal architecture in myeloid malignancies
    Meeting Abstract

    Miles, L. A.; Bowman, R. L.; Merlinsky, T. R.; Ooi, A.; Mendez, P.; Famulare, C.; Patel, M. A.; Bolton, K.; Palmisiano, N.; Carroll, M. P.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
    Journal Article

    Rustad, E. H.; Misund, K.; Bernard, E.; Coward, E.; Yellapantula, V. D.; Hultcrantz, M.; Ho, C.; Kazandjian, D.; Korde, N.; Mailankody, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save